Outsourcing global clinical

& medical engagement for accelerated drug approval

& acceptance

Flexible, scalable sales teams for rapid product launch

& lifecycle management

AnswerY™, an AI-driven, HIPAA-compliant platform of prescriber-patient conversations that drives next-best actions

Premium content & audience access to critical oncology care networks

Continuous growth for teams and individuals led by pharma industry experts

Pioneering Innovation

Our News

Read Article arrow
August 1, 2025
Read Article arrow
July 31, 2025
Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS) are rare, childhood-onset, developmental epileptic encephalopathies.
Explore Research arrow
May 30, 2025
There is a growing push to leverage diverse data sources to enrich RWD insights. 
Read Article arrow
May 29, 2025
Meet Ava, Amplity’s new AI-powered chatbot designed to deliver faster, more personalized digital experiences on .
Read Article arrow
May 28, 2025
NLP Unlocks Patterns In Myasthenia Gravis Progression
Explore Research arrow
May 21, 2025
Myasthenia gravis (MG) is a rare, chronic, autoantibody-mediated neuromuscular disorder.
Explore Research arrow
May 21, 2025
Lung cancer is a common and deadly cancer in the United States.
Explore Research arrow
May 21, 2025
Imflammatory bowel disease can be treated with biologics.
Explore Research arrow
May 15, 2025

Events and Webinars

No events to see right now — but exciting things are on the way! Check back soon.
Powerful Partnerships Start Here